Similarly, hemoglobin A1c levels demonstrated a decreasing trend at 1 and 3 years compared to the baseline, with no significant differences between the two treatment groups ( Supplementary Tables 1 and 2 ). 2.
← all excerpts
Comparison of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Steatotic Liver Disease.
1
—
—